% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • riverfront418 riverfront418 Jul 16, 2014 2:33 AM Flag

    Momenta Pharmaceuticals Announces Date of Second Quarter 2014 Financial Results Conference Call and Webcast

    We will hear the same drivel "working with the FDA'. Cutting other programs cuz no relief in sight. Unless they have to now do patient trials.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Well. Damn hate being right. Same drivel of working with FDA , Copaxone generic looks to go all the way till October for the supreme court and then still no FDA approval. They are starting trials with Baxter for their lead product. Guess Baxter saw the problem they are having with Copaxone candidate. And they are dropping an Oncology program.. Waiting till October to revisit any potential increase. Good news is they still have enough cash not to push thru a secondary offering, and if they get approval any time this year they will not do one.

      Sentiment: Hold

    • cmhe Jul 24, 2014 11:22 AM Flag

      If they have to do patient trials , this will drop big.

16.54-0.18(-1.08%)Oct 9 4:00 PMEDT